Placebo Cohort A

OTHER2 trials

Sponsors

Regenera Pharma Ltd, International Vaccine Institute

Conditions

Cholera Vaccination ReactionNonarteritic Anterior Ischemic Optic Neuropathy

Phase 1

Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults

CompletedNCT05559983

International Vaccine InstituteCholera Vaccination Reaction

Start: 2022-12-05End: 2024-01-23Updated: 2025-03-25

Phase 2

Efficacy & Safety of RPh201 Treatment in Patients With Previous Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

TerminatedNCT03547206

Regenera Pharma LtdNonarteritic Anterior Ischemic Optic Neuropathy

Start: 2018-07-10End: 2020-09-27Updated: 2020-10-12